# Cirrus Therapeutics, Inc. — Form D

Cirrus Therapeutics, Inc. of Cambridge, MA, a company, filed a Form D exempt-offering notice with the SEC on 2025-08-19. The offering totals $15.7M, of which $6.7M was reported sold. Industry: Other Technology.

## Offering

- Filed: 2025-08-19
- Form: D
- Accession: 0002070295-25-000002
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $15.7M
- Amount sold: $6.7M
- Remaining: $9.0M
- Investors: 8
- Date of first sale: 2025-08-04
- Security types: equity
- Revenue range: Not Applicable
- SEC file number: 021-555163

## Issuer

- Name: Cirrus Therapeutics, Inc.
- CIK: 0002078601
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 750 Main Street, Cambridge, MA, 02139
- Phone: (617) 959-3124

## Officers, directors & promoters (7)

| Name | Role | Location |
| --- | --- | --- |
| Alexandra Cantley | Director | Newton, MA |
| Ying Kai Chan | Director | Cambridge, MA |
| Andrew Dick | Director | Cambridge, MA |
| Khoo Shih | Director | Cambridge, MA |
| Ying Kai Chan | Executive Officer | Cambridge, MA |
| Ying Kai Chan | Promoter | Cambridge, MA |
| Andrew Dick | Promoter | Cambridge, MA |

## More

- [CIK 2078601 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2078601&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002070295-25-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.